i
Important informations

LDI

The Lady Davis Institute for Medical Research

The research arm of the Jewish General Hospital

The LDI is among Canada’s leading health research institutes. Through their fundamental and clinical investigations, our scientists and clinicians make significant discoveries, lead important provincial and national research programs, and train emerging scientists who, themselves, are recognized for the excellence of their work, contributing to the health and well-being of patients in Quebec, Canada, and around the world.

Empowering research excellence and innovation

At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.

Discover our 200+ regular and associated investigators and their research, as well as the many services we provide across the spectrum of the research process.

We offer the 250+ graduate and postdoctoral students who come to the LDI each year an open, collaborative, and multidisciplinary training environment that fosters excellence.

The close collaboration between researchers, clinicians, and patients is at the basis of the most successful research programs and clinical trials at the LDI.

Empowering research excellence and innovation

At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.

Latest News

Research news

Tweets

Emeritus

Human Genetics, Inherited eye diseases, Photoreceptors, Retinal and eye development, Retinal degeneration

Cancer

Bladder cancer, Drug discovery, Drug resistance, Immunotherapies, Melanoma, Metastatic cancers, Prostate cancer, Target and drug discovery, Therapeutic resistance

Psychosocial aspects of disease

Access, Biomarkers, Interventions, Mental Health, Oncology, Palliative Care, Prevention, Quality of life

Clinical Epidemiology

Cancer, Indigenous Health, Pharmacoepidemiology, Preventive Medicine, Public Health

Cancer

Basal cell carcinoma, Biobanking, Biomarkers, Computational biology, Dermatology, Genomics, Skin cancer, Transcriptomics, Translational research, Tumor microenvironment

Clinical Epidemiology

Deep vein thrombosis, Pharmacoepidemiology, Population studies, Pulmonary embolism, Venous thrombosis

Molecular & Regenerative Medicine

Aging, DNA damage, DNA replication, Genome integrity, Post-translational modifications, Recombination, Ribonucleoprotein assembly, Telomerase, Telomere

Molecular & Regenerative Medicine

AIDS/HIV, Gene expression, Immunology, Infectious diseases, Retroviruses, RNA biology, RNA trafficking, RNA virus, Therapeutics, Virus-host interactions

National Collaborations and Partnerships